Enhanced translation of IGF2 and IGF1R occurs via the de novo expression of the oncofetal RNA-binding proteins IGF2BPs (IGF2BP1, IGF2BP2, IGF2BP3) in different tumor types [10,12,87,88,89]. Here, IGF2BP3 is linked to neoplasm.